FDA slaps a hold on Voyager's lead gene therapy over 'MRI abnormalities'
A rocky year for gene therapy is closing out with more bleak news.
Voyager Therapeutics announced Tuesday that the FDA has forced the company to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
